STOCK TITAN
  1. Home
  2. News
  3. OGI

Organigram Holdings Inc. Common Shares - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

News

Organigram Completes First Shipment to Germany, Extending its International Reach

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, as part of its multi-year agreement. The company will provide high-quality, indoor-grown dried flower product to Sanity Group and grant strain exclusivity on certain genetics. The inaugural shipment contains Organigram’s exceptional Super G Citra strain. This expansion into international markets reflects the company's commitment to quality, consistency, and consumer focus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
-
News

Organigram Announces the First Tranche Closing from BAT Investment

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has closed the first tranche of a C$124,559,674 strategic equity investment by BT DE Investments Inc., a subsidiary of British American Tobacco plc. The Investor acquired 12,893,175 common shares at C$3.2203 per share, with the remaining shares to be issued in two further tranches. The investment will be used to create a strategic investment pool, named Jupiter, targeting emerging cannabis opportunities for geographic expansion. Organigram's 10 years of experience and successful cannabis investments position it for global growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.51%
Tags
none
-
News

Organigram Announces Appointment of Karina Gehring to Board of Directors

Rhea-AI Summary
Organigram Holdings Inc. appoints Karina Gehring to the Board of Directors, representing British American Tobacco plc. Gehring brings over 25 years of marketing and trade experience and is expected to provide valuable insights and expertise to the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.71%
Tags
management
News

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

Rhea-AI Summary
Organigram Holdings Inc. announced the results of its annual general and special meeting of shareholders, including the election of directors, committee composition, appointment of auditor, and shareholder approval of investment and articles of amendment. KPMG LLP was approved as the Company's auditor, and a C$124.6 million follow-on strategic equity investment was approved by the shareholders. The Investment is expected to close on or around January 23, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.71%
Tags
none
-
News

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Rhea-AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced a special meeting to approve a $124.6 million investment from BAT at $3.2203/share and the creation of the 'Jupiter' strategic investment pool. The investment is subject to approval by shareholders at the meeting to be held on January 18, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.09%
Tags
none
-
News

Organigram Reports Fiscal 2023 Results¹

Rhea-AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its Fiscal 2023 results, including net revenue of $161.6 million, a 11% increase from the previous year, and an adjusted gross margin of $40.2 million, up 20% from the previous year. The company secured a $124.6 million private placement transaction with BAT-Jupiter, strengthened its market position, and achieved significant growth in several product categories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
earnings
News

Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has appointed Greg Guyatt as the new Chief Financial Officer, effective January 8, 2024. Mr. Guyatt brings over 25 years of international public company and private equity backed company experience to the role, replacing Paolo De Luca. The company aims to focus on ambitious growth plans and delivering bottom-line results under his leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
management
-
News

Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023

Rhea-AI Summary
Organigram Holdings Inc. (OGI) to Report Q4 and Fiscal 2023 Earnings Results on December 19, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
conferences earnings
-
News

Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has won KIND Magazine’s 'Innovation of the Year' award for its SHRED X Rip-Strips Hash, marking the second consecutive win for the company. The award recognizes Organigram's commitment to consumer-focused innovation in the cannabis sector. The company was also nominated in four other categories, showcasing its strong presence and product offerings in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
none
News

Organigram Increases Investment in Phylos After Successful Milestone Achievement

Rhea-AI Summary
Organigram Holdings Inc. (OGI) advances grow room conversion with custom designed F1 Hybrid seeds, aiming to reduce cultivation costs and produce high-potency, terpene-rich cultivars. The company has closed the second tranche of a loan agreement with Phylos Bioscience Inc., advancing US$2.75 million to further its cannabis genetics research and development. Organigram is on track to convert over 30% of its Moncton facility's cultivation space to F1 Hybrid seed grow by the end of FY24.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
none

FAQ

What is the current stock price of Organigram Holdings Common Shares (OGI)?

The current stock price of Organigram Holdings Common Shares (OGI) is $1.52 as of November 22, 2024.

What is the market cap of Organigram Holdings Common Shares (OGI)?

The market cap of Organigram Holdings Common Shares (OGI) is approximately 166.1M.

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.

Stock OGI logo
Organigram Holdings Inc. Common Shares

Nasdaq:OGI

OGI Rankings

#4015 Ranked by Market Cap
N/A Ranked by Dividends

OGI Stock Data

166.12M
75.87M
31.32%
9.73%
2.11%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto